77 related articles for article (PubMed ID: 2942692)
1. Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy.
Lazzarin A; Galli M; Moriondo P; Parravicini C; Poli G; Moroni M
J Clin Lab Immunol; 1986 Jun; 20(2):57-61. PubMed ID: 2942692
[TBL] [Abstract][Full Text] [Related]
2. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
[TBL] [Abstract][Full Text] [Related]
3. T lymphocytes in children with recurrent respiratory infections: effect of the use of thymostimulin on the alterations of T-cell subsets.
De Martino M; Rossi ME; Muccioli AT; Vierucci A
Int J Tissue React; 1984; 6(3):223-8. PubMed ID: 6332795
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effect of a calf thymus extract (thymostimulin) on T cell phenotypes in cord blood lymphocytes.
Velardi A; Gerli R; Rambotti P; Spinozzi F; Cernetti C; Angelini A; Martelli MF
Am J Reprod Immunol (1980); 1982 Oct; 2(5):250-3. PubMed ID: 6217758
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans.
Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C
Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of a bovine thymic extract (thymostimulin) on T-cell differentiation in cord blood lymphocytes.
Lin CY; Chu CM
Pediatr Pharmacol (New York); 1985; 5(3):181-7. PubMed ID: 3879346
[TBL] [Abstract][Full Text] [Related]
7. Effect of a thymic extract (Tp-I) in a case of angio-immunoblastic lymphadenopathy (A.I.L.).
Caputo G; Leone G; Bizzi B
Haematologica; 1982; 67(6):943-4. PubMed ID: 6819201
[No Abstract] [Full Text] [Related]
8. [Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon].
Galli M; Lazzarin A; Poli G; Negri C; Orlando G; Crocchiolo P; Moroni M
Quad Sclavo Diagn; 1985 Sep; 21(3):322-9. PubMed ID: 3879700
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and immunologic studies of the use of thymus polypeptide factor (thymostimulin) in chronic mucocutaneous candidiasis].
Lutz G; Niedecken HW; Bauer R; Kreysel HW
Hautarzt; 1986 Mar; 37(3):142-5. PubMed ID: 3486176
[TBL] [Abstract][Full Text] [Related]
10. A study of T lymphocyte subpopulations by monoclonal antibodies in a case of angio-immunoblastic lymphadenopathy with dysproteinemia.
Cavanna L; Fornari F; Tansini P; Ajolfi C; Rossi S; Prati C; Panelli R; Groppi F; Contini P; Bottinelli S; Silva ML; Buscarini L
Haematologica; 1983; 68(3):405-10. PubMed ID: 6224724
[No Abstract] [Full Text] [Related]
11. Isolation of T lymphocyte subsets from peripheral blood using monoclonal antilymphocyte antibodies.
Patel R; Soriano A; Loeb L; Ghoneum M; Najera D
Ann Clin Lab Sci; 1985; 15(1):66-70. PubMed ID: 3155926
[TBL] [Abstract][Full Text] [Related]
12. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
[TBL] [Abstract][Full Text] [Related]
13. [Generalized persistent lymphadenopathy syndrome in parenteral drug addicts. Lymph node biopsy study of 41 patients].
Vera-Sempere G; Vera-Sempere FJ; Guix-García J
An Med Interna; 1990 Dec; 7(12):621-6. PubMed ID: 2135574
[TBL] [Abstract][Full Text] [Related]
14. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
[TBL] [Abstract][Full Text] [Related]
15. Persistent generalized lymphadenopathy in drug addicts: immunological studies.
Barcellini W; Meroni PL; Lazzarin A; Sguotti C; Parravicini C; Borghi MO; Brucato A; Moroni M; Sirianni MC; Aiuti F
Boll Ist Sieroter Milan; 1986; 65(4):269-76. PubMed ID: 3539149
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of immunotropic preparations in chronic bronchitis].
Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Semin SN; Ogarkov VI
Ter Arkh; 1988; 60(3):42-5. PubMed ID: 2968678
[No Abstract] [Full Text] [Related]
17. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
18. [Study of blood T-lymphocyte subpopulations in ankylosing spondylarthritis using monoclonal antibodies].
Le Goff P; Ferec C; Brousse A; Tande D; Youinou P
Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):325-30. PubMed ID: 6236543
[TBL] [Abstract][Full Text] [Related]
19. Effect of colchicine on T cell subsets of healthy volunteers.
Ilfeld D; Feierman E; Kuperman O; Kivity S; Topilsky M; Netzer L; Pecht M; Trainin N
Immunology; 1984 Nov; 53(3):595-8. PubMed ID: 6237988
[TBL] [Abstract][Full Text] [Related]
20. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]